Introduction
NACHT leucine-rich-repeat protein 1 (NALP1) or NLR family, pyrin domain containing 1 (NLRP1), is a member of the nucleotide oligomerization domains (NOD)-like receptors (NLRs) family, which are cytoplasmic proteins that sense endogenous microbial products and metabolic stresses, thereby stimulating innate immunity. In humans, NLRs include several members of the NALP family, interleukin-1b (IL-1b)-converting enzyme protease activating factors, neuronal apoptosis inhibitory factors, major histocompatibility complex class II transactivator and five members of the NOD subfamily. NLRs associate with other proteins forming multiprotein cytoplasmic complexes that mediate the activation of inflammatory caspases, which can further activate proinflammatory cytokines and promote inflammation. [1] [2] [3] [4] NALP1 provides a scaffold for the assembly of the inflammasome that activates caspases 1 and 5, which subsequently promote the processing and maturation of the inflammatory cytokines, pro-IL-1b, IL-18 and IL-33. [3] [4] [5] [6] [7] Apoptosomes are also formed with NALP1, caspase-2 and caspase-9, suggesting a role for NALP1 in the regulation of apoptosis and cell survival. 8 The strong expression of NALP1 in immune cells, particularly the Langerhans cells and T cells, underscores its potential role in autoimmunity.
A link between NLRs and autoimmunity was recently provided by Jin and co-workers, 9 ,10 who showed an association of polymorphisms in NALP1 and generalized vitiligo and vitiligo-associated autoimmune disorders. They suggested the existence of two distinct associated regions within the NALP1 locus, one spanning the 5 0 part of the gene, including the promoter, and another locus covering the 3 0 end of the gene, tagged by rs6502867. To examine whether the NALP1 gene could play a more general role in autoimmunity, we tested the associations of four single nucleotide polymorphisms (SNPs) with a number of autoimmune diseases. We found associations with autoimmune Addison's disease and type 1 diabetes, and similar trends for multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Juvenile idiopathic arthritis was not associated with any of the tested SNPs in NALP1.
Results
First, we analyzed patients with autoimmune Addison's disease (n ¼ 333), type 1 diabetes (n ¼ 1086) and multiple sclerosis (n ¼ 502) against two groups of healthy controls (n ¼ 2269) for association with the tag SNPs rs12150220, rs2670660, rs878329 and rs6502867 in NALP1. All SNPs were in the Hardy-Weinberg equilibrium in each stratum, apart from the marker rs6502867 in the multiple sclerosis patients ( Table 2 ). The two control cohorts were genotyped at two different centers, but had almost identical allele frequencies across all SNPs (P40.76), and were therefore pooled in all analyses presented. The SNP rs12150220 (p.Leu155His) was significantly associated with both autoimmune Addison's disease (OR ¼ 1.27, 95% CI: 1.06-1.49, P ¼ 0.006) and type 1 diabetes (OR ¼ 1.16, 95% CI: 1.04-1.28, P ¼ 0.006) ( Table 1) . The other three SNPs showed trends of association with Addison's disease, whereas two of them (rs2670660 and rs878329) showed trends of association with type 1 diabetes ( We next extended the analyses by genotyping rs6502867 and rs12150220 in patients affected with three other autoimmune diseases, that is rheumatoid arthritis, systemic lupus erythematosus and juvenile idiopathic arthritis, and an additional set of healthy controls. Although a trend for association in the same direction as autoimmune Addison's disease and type 1 diabetes was seen in rheumatoid arthritis and systemic lupus erythematosus for rs12150220, it did not reach statistical significance. Juvenile idiopathic arthritis was not associated with either of the NALP1 SNPs (Table 2) .
Linkage disequilibrium (LD) analysis showed the existence of strong LD between the exon 3 SNP rs12150220 and the two SNPs upstream of the gene (rs2670660 and rs878329), whereas very little LD seemed to extend to rs6502867 located in the 3 0 part of the gene Figure 1) .
Discussion
NALP1 is believed to mediate inflammation and autoimmunity partly due to its ability to associate with the adapter protein ASC, caspase-1 and caspase-5, to form inflammasomes that are central in the activation of proinflammatory IL-1b. 3, 5, 8 Polymorphisms of NALP1 have been reported to confer risk for vitiligo and/or extended autoimmune/ inflammatory disorders in Caucasian patients from the United Kingdom and the United States, 9 and more recently from Romania. 10 The current report provides further evidence of the involvement of NALP1 in the pathophysiology of autoimmune diseases. The association of a polymorphism in NALP1 with autoimmune Addison's disease and type 1 diabetes, combined with the lack of significant association with the systemic autoimmune disorders systemic lupus erythematosus and juvenile idiopathic arthritis, may indicate a specific role in organ-specific autoimmunity. However, the lack of statistical significance for an association between genetic variants in NALP1 and the systemic diseases tested here might also be a result of the lack of statistical power.
We found that the major allele of rs12150220 in NALP1 was associated with increased risk of disease, whereas the earlier reported risk of vitiligo and complex autoimmunity was associated with the minor allele. 9 Our result was verified by sequencing eight samples (data not shown), to ensure that here we report the correct association. The discrepancy may be due to population differences in allele frequencies, well known from studies of the major histocompatibility complex (MHC).
11 Contrary to our results, a recent genome-wide association study of type 1 diabetes and rheumatoid arthritis implicated neither chromosome 17 nor the NALP1 gene. 12, 13 However, none of the SNPs tested were highly correlated with the SNP that we have found to be associated with autoimmunity. Actual genotyping of rs12150220 in a Wellcome Trust Case Control Consortium (WTCCC) 15 K scan (British population) revealed no significant statistical differences between patients with multiple sclerosis and controls (http://www.wtccc. org.uk/info/summary_stats.shtml). The relatively weak effect of the association in addition to ethnic variations of the studied cohorts could explain some of the divergence of the data. It can be noted that the minor allele frequencies for the control groups observed in the WTCCC study varied slightly compared with this study.
Despite the relatively large number of cases and controls ascertained in this study we do not have sufficient power to reach genome-wide significance. The P-values are presented without correction for multiple comparisons. Using a classical conservative Bonferroni correction for the primary analysis would set the study-wide significance threshold to Po0.004 (N ¼ 12, four SNPs and three phenotypes), which is slightly lower than the P-values detected for AAD and T1D separately, i.e. 0.007 and 0.005, respectively (Table 2) . However, a Bonferroni correction might be too conservative given that three of the four SNPs tested are highly correlated. We also argue that the general trend for increased risk in all but one of the disease groups studied combined with the P-value of 0.0005 for the pooled autoimmune Addison's disease and type 1 diabetes samples suggest that the results might reflect a biological effect rather than a type 1 error.
More studies of well-characterized patients with various autoimmune diseases should be performed to gain more information on the involvement of the NALP1 14 with functions in controlling immune and inflammatory responses. Maybe the best-studied member of this group is the MHC class II transactivator (MHC2TA) crucial for the expression of MHC class II molecules. Mutations in the MHC2TA gene gives rise to the bare lymphocyte syndrome, a fatal condition where patients succumb in bacterial, viral, fungal and protozoan infections.
14 Intriguingly, polymorphisms in the MHC2TA locus is associated with a number of autoimmune diseases, among them Addison's diseases. 15 Mutations in another gene of this family known as caspase recruitment domain 15 (CARD 15) or NOD2 is associated with Crohn's disease, 16 early-onset sarcoidosis and Blau syndrome characterized by granulomatous synovitis, non-granulomatous uveitis and cranial neuropathies. 14, 17 Mutations in NALP3 coding for cryopyrin are causative for the auto-inflammatory diseases, such as familial cold autoinflammatory syndrome, the MuckleWells syndrome and neonatal-onset multisystem inflammatory disease.
14 The three diseases are now considered to be a continuum referred to as cryopyrin-associated periodic syndrome. Most of the mutations are found in the NACHT domain, close to where rs12150220 in NALP1 is located. This indirectly supports that the Leu/His amino acid variation at position 155 modulates NALP1 function and the way inflammasomes processes microbial products.
IL-1b, one of the mediators of inflammasome activation, has been shown to be cytotoxic to insulin-producing islet cells in vitro. 18 Possibly, variation in the inflammasome activation could influence antigen presentation and subsequently tolerance to self. Functional studies of NALP1 variants and association studies with other disorders are needed to further elucidate NALP1's possible role in autoimmune diseases.
Patients and methods
Patients and controls All together, 333 Norwegian patients with autoimmune Addison's disease were recruited from a national registry of organ-specific autoimmune diseases. The diagnosis was based either on a low basal serum cortisol and high adrenocorticotropic hormone or on a pathological adrenocorticotropic hormone stimulation test. A total of 145 patients had type 1 diabetes and/or thyroid diseases in addition to Addison's disease, that is APS II.
The cohort of patients with type 1 diabetes consisted of 1086 individuals with disease onset before 17 years of age, recruited from the nationwide Norwegian Childhood Diabetes Registry from 2002, as detailed elsewhere. 19 They were all diagnosed according to the EURODIAB criteria. 20 The human leukocyte antigen haplotypes for type 1 diabetes were grouped as high risk, intermediate risk, neutral risk and low risk. 19 Furthermore, a total of 502 patients with definite multiple sclerosis, 21 945 patients with rheumatoid arthritis, 156 systemic lupus erythematosus patients and 505 juvenile idiopathic arthritis patients were included. All rheumatoid arthritis and lupus patients fulfilled the American College of Rheumatology criteria, 22, 23 and the juvenile idiopathic arthritis patients were classified according to the International League of Associations for Rheumatology criteria. 24 Information on demographic variables of the patients is summarized in Table 3 . A total of 3273 anonymous healthy Norwegian blood donors or donors from the Norwegian bone marrow donor registry were used as controls. All patients and controls provided informed written consent. Relevant medical research ethics committees approved the study.
SNPs selection and genotyping
On the basis of earlier studies by Jin et al.
9,10 we selected representative SNPs across the NALP1 gene, tagging the two autoimmunity-associated regions, SNP rs6502867, located in intron 15 of the NALP1 gene, and another LD block tagged by rs12150220 in exon 3 of NALP1, and two promoter region SNPs (rs2670660 and rs878329). The SNP rs12150220A/T (p.Leu155His) was also selected due to its potential functional significances, as it changes a leucine to histidine in exon 3. Genotyping was performed by commercially available Taqman assays (Applied Biosystems, Foster City, CA, USA).
TaqMan reactions were set up based on the manufacturer's protocol and the samples were run on an ABI7900HT II Fast Real-Time instrument. Allelic discrimination was performed as suggested by the manufacturer, and analyzed using the SDS software (v. 2.3). The automated genotype calling was supplemented by manual inspection by two independent persons and the results compared.
Sequencing
We sequenced the region covering the rs12150220 A/T non-synonymous SNP in eight known patient samples to confirm which strand was detected by the TaqMan assay. The PCR reactions were set up in a standard manner and the products were purified using ExoSAP-IT (USB Corporation, Cleveland, OH, USA). We then The mean ages of the JIA and RA patients were calculated based on 148 and 214 patients, respectively.
sequenced the coding strands of the region surrounding the SNP using ABI prism BigDye terminator kit v.3.1 and an ABI3730 DNA analyzer (Applied Biosystems). The sequences were analyzed using CLC Combined Workbench v. 3 (CLS Bio, Cambridge, MA, USA).
Statistical analysis
The Progeny software (Progeny Software Inc., Nova Scotia, Canada) was used for handling of the genotype data. The data were transferred to the Plink software 25 in which all the genetic association tests were performed. For the conditional analysis, we used logistic regression with rs12150220 genotypes included as co-variate. The Haploview software 26 was used to investigate the linkage LD pattern both in our data set and in HapMap data. P-values o0.05 were considered significant, and all P-values were presented without correction for multiple testing. A formal Bonferroni correction for the number of tests performed for the primary hypothesis (four SNPs tested in three diseases) would require a study-wide significance threshold of Po0.004.
